Omega Diagnostics Group PLC Grant of Share Options (2383V)
02 December 2019 - 8:00PM
UK Regulatory
TIDMODX
RNS Number : 2383V
Omega Diagnostics Group PLC
02 December 2019
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Grant of Share Options and Notification of Director / PDMR
Dealings
Omega Diagnostics (AIM: ODX), the medical diagnostics company
focused on CD4, food intolerance and allergy testing, announces
that the Group's Remuneration Committee and the Board have approved
the grant of 500,000 options ("New Options") over ordinary shares
of 4 pence each ("Ordinary Shares") to Jeremy Millard,
Non-Executive Director, pursuant to the Group's existing share
option schemes.
All New Options were granted with an exercise price of 10 pence
each, being the closing middle market price on 29 November 2019.
The New Options will vest over three years, one third vesting on
each anniversary of the grant date.
The grant of 500,000 New Options equates to 0.33 per cent. of
the Group's current issued share capital. In total, 9,420,406
options are now under grant but not exercised, which equates to 6.3
per cent. of the Group's current issued share capital.
The FCA notification, made in accordance with the requirements
of the EU Market Abuse Regulation is appended below.
The information communicated in this announcement is inside
information for the purposes of Article 7 of EU Regulation
596/2014.
Contacts:
Omega Diagnostics Group PLC Tel: 01259 763 030
Bill Rhodes, Interim Non-Executive www.omegadiagnostics.com
Chairman
Colin King, Chief Executive
Kieron Harbinson, Group Finance
Director
Mob: 07740 084452
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/Hannah Boros (Corporate
Finance)
Camille Gochez (Corporate Broking)
Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303
Details of the person discharging managerial responsibilities/person
closely associated
a) Name: Jeremy Millard
----------------------------------------- -----------------------------------------------------------------
Reason for the notification
------------------------------------------------------------------------------------------------------------
a) Position/status: Non-Executive Director
----------------------------------------- -----------------------------------------------------------------
b) Initial notification/Amendment: Initial Notification
----------------------------------------- -----------------------------------------------------------------
Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
------------------------------------------------------------------------------------------------------------
a) Name: Omega Diagnostics Group Plc
----------------------------------------- -----------------------------------------------------------------
b) LEI: 2138007U9P4BTZTYIR92
----------------------------------------- -----------------------------------------------------------------
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been conducted
------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, Ordinary Shares of 0.5 pence each
type of instrument: GB00B1VCP282
Identification code:
----------------------------------------- -----------------------------------------------------------------
b) Nature of the transaction: Grant of options over Ordinary Shares
----------------------------------------- -----------------------------------------------------------------
c) Price(s) and volume(s): Price(s) Volume(s)
n/a 500,000
----------
----------------------------------------- -----------------------------------------------------------------
d) Aggregated information: Single transaction as in 4 c) above Price(s) Volume(s) Total
* Aggregated volume: n/a 500,000 n/a
---------- ------
* Price:
----------------------------------------- -----------------------------------------------------------------
e) Date of the transaction: 2 December 2019
----------------------------------------- -----------------------------------------------------------------
f) Place of the transaction: n/a
----------------------------------------- -----------------------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCFSSFAFFUSELE
(END) Dow Jones Newswires
December 02, 2019 04:00 ET (09:00 GMT)
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Apr 2024 to May 2024
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From May 2023 to May 2024